Benzinga | Jan 13, 2022 11:46AM EST

iSpecimen Announces Addition Of Reference Lab In New York To 'support commercial and government customers focused on COVID-19 research'

LEXINGTON, Mass., Jan. 13, 2022 /PRNewswire/ -- iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the expansion of its supplier capabilities with the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research, including analyzing the Omicron and Delta variants. The reference lab, a recent addition to the iSpecimen supplier network, has the capacity to sequence hundreds of COVID-19 positive swabs per week, providing data that is crucial in the fight against the virus. This lab is sequencing the most recent swabs to identify new variants of COVID-19 as the virus continues to progress globally.